Corpus ID: 163713316

Standardized Definitions for Cardiovascular and Stroke Endpoint Events in Clinical Trials

@inproceedings{Hicks2014StandardizedDF,
  title={Standardized Definitions for Cardiovascular and Stroke Endpoint Events in Clinical Trials},
  author={Karen Anne Hicks and H. M. James Hung and Kenneth W. Mahaffey and Roxana Mehran and Steven E Nissen and Norman L. Stockbridge and Shari L. Targum and Robert J. Temple and Steve Bai and Steven S. Brooks and Paul R. Burton and Kenneth J. Cavanaugh and Bernard R. Chaitman and Brian C. Clark and Donald E. Cutlip and Akshay S. Desai and Michael J. Domanski and Billy Dunn and Andrew A Farb and Heather D. Fitter and C Michael Gibson and James Hung and Ilan Irony and Michael R. Jaff and Cheri D Janning and Hylton V. Joffe and Bron Kisler and Judith M. Kramer and Rebecca Daniels Kush and Martin J Landray and Alexandra J. Lansky and John Lawrence and Jonathan G. Levine and Eldrin F. Lewis and Abraham Michael Lincoff and John R. Marler and Laura Mauri and Brian J. McCourt and John J. V. McMurray and Yale B. Mitchel and Jean Morgan and David A. Morrow and Mary H. Parks and Douglas Peddicord and Marc A. Pfeffer and Kenneth Rosenfield and Leonard Sacks and Cathy Sila and Benjamin Morgan Scirica and Karen Snowdon-Way and Scott D. Solomon and Steven R. Steinhubl and Barbara E. Tardiff and James E. Tcheng and John R. Teerlink and Chris Tolk and Ellis F. Unger and Christopher J. White and Stephen D. Wiviott and Bram D. Zuckerman},
  year={2014}
}
Working Groups: Kenneth W. Mahaffey, Roxana Mehran, and Steven E. Nissen, Co-ordinators; Steve Bai, Steven S. Brooks, Paul Burton, Kenneth J. Cavanaugh, Bernard R. Chaitman, B. Christine Clark, Donald E. Cutlip, Akshay S. Desai, Michael J. Domanski, Billy Dunn, Andrew Farb, Heather D. Fitter, C. Michael Gibson, Karen A. Hicks, H. M. James Hung, Kachikwu Illoh, Ilan Irony, Michael R. Jaff, Cheri Janning, Hylton V. Joffe, Bron Kisler, Judith M. Kramer, Rebecca Kush, Martin J. Landray, Alexandra… Expand
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials
TLDR
This document was approved by the American Heart Association Science A College of Cardiology Board of Trustees on November 12, 2014 and is available on the World Wide Web sites of the Association (my.americanheart.org). Expand
Methodology of a reevaluation of cardiovascular outcomes in the RECORD trial: study design and conduct.
TLDR
Comprehensive procedures were used for rigorous event reascertainment and readjudication in a previously completed open-label, global clinical trial and were enhanced to address the FDA concerns about the original RECORD trial results. Expand
Mode of Death in Heart Failure With Preserved Ejection Fraction.
TLDR
There is an unmet need for a longitudinal multicenter, global registry of patients with HFpEF to map its natural history and reporting and definitions of modes of death must be standardized and tailored to the HFp EF population. Expand
Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials
TLDR
In 9 cardiometabolic clinical trials with long-term follow-up, approximately 16% of deaths had undetermined causes, a baseline for quality assessment of clinical trials and informs operational efforts to potentially reduce the frequency of undetermined deaths in future clinical research. Expand
Centralized adjudication of cardiovascular end points in cardiovascular and noncardiovascular pharmacologic trials: a report from the Cardiac Safety Research Consortium.
TLDR
Recommendations from the think tank regarding when CV end point adjudication should be considered in trials conducted by cardiologists and by noncardiologists are presented as well as detailing key issues in the composition of a CEC and its charter. Expand
Identification and Validation of Major Cardiovascular Events in the United Kingdom Data Sources Included in a Multi-database Post-authorization Safety Study of Prucalopride
TLDR
The validation process for MACE endpoints in United Kingdom data sources: Clinical Practice Research Datalink, The Health Improvement Network, and the Information Services Division (ISD) Scotland followed a common protocol, adapted for each database, with all information anonymized. Expand
Outcomes in patients with acute coronary syndrome in a referral hospital in sub-Saharan Africa.
TLDR
The in-hospital, 30-day and one-year mortality rates following ACS remain high, particularly for STEMI patients, and delayed presentation to hospital following symptom onset is a major concern. Expand
Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored.
TLDR
It is believed that heart failure should be systematically evaluated in cardiovascular outcome trials of all new glucose-lowering drugs. Expand
A randomized, placebo-controlled study of the cardiovascular safety of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus
TLDR
In this CV safety study of patients with T2DM and established CV disease, omarigliptin did not increase the risk of MACE or hHF and was generally well tolerated. Expand
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards).
TLDR
The American College of Cardiology and the American Heart Association support their members’ goal to improve the care of patients with cardiovascular disease through professional education, research, and development of guidelines and standards and by fostering policies that support optimal patient outcomes. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 30 REFERENCES
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi
TLDR
Elliott M. Antman,MD, FACC, FAHA, Chair; Daniel T. Anbe, MD, F ACC,FAHA; Paul Wayne Armstrong, MD; Eric R. Bates; Lee A. Green; Mary Hand; Judith S. Kushner; and Sidney C. Sloan. Expand
2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Forc
2012 WRITING GROUP MEMBERS* Hani Jneid, MD, FACC, FAHA, Chair†; Jeffrey L. Anderson, MD, FACC, FAHA, Vice Chair†‡; R. Scott Wright, MD, FACC, FAHA, Vice Chair†; Cynthia D. Adams, RN, PhD, FAHA†;Expand
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
TLDR
The 2017-18 FAHA/FACC/FAHA Education and Research Grants will be focused on advancing the profession’s understanding of central nervous system disorders and the management of post-traumatic stress disorder. Expand
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
TLDR
The 2017-18 FAHA/FACC/FAHA Education and Research Grants will be focused on advancing the profession’s understanding of central nervous system disorders and the management of post-traumatic stress disorder. Expand
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
TLDR
The 2017-18 FACC-FAHA curriculum vitae will be presented in June, with a focus on teaching, research, and awareness of adolescent and young people’s experiences with FACC. Expand
2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standar
TLDR
This research presents a meta-analyses of the immune system’s response to infectious disease and its applications to FACC and FSCAI, which shows clear patterns of decline in the vaccinated and the uninjured. Expand
ESC GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF ACUTE AND CHRONIC HEART FAILURE 2008
Authors/Task Force Members: Kenneth Dickstein (Chairperson) (Norway)*, Alain Cohen-Solal (France), Gerasimos Filippatos (Greece), John J.V. McMurray (UK), Piotr Ponikowski (Poland), Philip AlexanderExpand
Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions
TLDR
Criteria for assessment of death, myocardial infarction, repeat revascularization, and stent thrombosis were developed and provide consistency across studies that can facilitate the evaluation of safety and effectiveness of these devices. Expand
Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document
TLDR
The HFA‐ESC convened a group of expert heart failure clinical investigators, biostatisticians, regulators, and pharmaceutical industry scientists to evaluate the challenges of defining heart failure endpoints in clinical trials and to develop a consensus framework, and this report summarizes the group's recommendations for achieving common views on heart failureEndpoint selection. Expand
An Updated Definition of Stroke for the 21st Century: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
TLDR
The Stroke Council of the American Heart Association/American Stroke Association convened a writing group to develop an expert consensus document for an updated definition of stroke for the 21st century that incorporates clinical and tissue criteria and can be incorporated into practice, research, and assessments of the public health. Expand
...
1
2
3
...